effectiveness of third-class biologic treatment in crohn’s disease: a multi-center retrospective cohort study

Autor: C. M. Alves, Henit Yanai, Morine Fibelman, Claire Liefferinckx, Marina Coletta, Hadar Amir-Barak, Johan Burisch, Afroditi Mpitouli, Manuel Barreiro-de Acosta, Mohamed Attauabi, Triana Lobaton, Mariann Rutka, Joshua Taylor, Konstantinos Karmiris, Javier P. Gisbert, Carla Marinelli, Kalliopi Foteinogiannopoulou, Daniela Pugliese, Edoardo Savarino, Borja Otero-Alvarin, V Domislović, Ariella Bar-Gil Shitrit, Alessandro Armuzzi, Zeljko Krznaric, Carl Eriksson, Mohamed Korani, Waqqas Afif, Jimmy K. Limdi, Nitsan Maharshak, Davide Giuseppe Ribaldone, A Cremer, G Suris, Tamás Molnár, Stéphane Nancey, Ioannis E. Koutroubakis, Jakob Benedict Seidelin, Caroline di Jiang, Uri Kopylov, Tim Raine, Pauliina Molander, Katja Tepes, Ahmad Albshesh, David Drobne, María Chaparro, Marie Truyens, Fernando Magro

Publikováno v: Albshesh, A, Taylor, J, Savarino, E V, Truyens, M, Armuzzi, A, Ribaldone, D G, Shitrit, A B G, Fibelman, M, Molander, P, Liefferinckx, C, Nancey, S, Korani, M, Rutka, M, Acosta, M B D, Domislovic, V, Suris, G, Eriksson, C, Alves, C, Mpitouli, A, Di Jiang, C, Tepeš, K, Coletta, M, Foteinogiannopoulou, K, Gisbert, J P, Amir-Barak, H, Attauabi, M, Seidelin, J, Afif, W, Marinelli, C, Lobaton, T, Pugliese, D, Maharshak, N, Cremer, A, Limdi, J K, Molnár, T, Otero-Alvarin, B, Krznaric, Z, Magro, F, Karmiris, K, Raine, T, Drobne, D, Koutroubakis, I, Chaparro, M, Yanai, H, Burisch, J & Kopylov, U 2021, ' Effectiveness of third-class biologic treatment in crohn’s disease : A multi-center retrospective cohort study ', Journal of Clinical Medicine, vol. 10, no. 13, 2914 . https://doi.org/10.3390/jcm10132914
JOURNAL OF CLINICAL MEDICINE
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, Vol 10, Iss 2914, p 2914 (2021)
Journal of Clinical Medicine
Volume 10
Issue 13

Background: Multiple studies have described the effectiveness of ustekinumab (UST) and vedolizumab (VDZ) in patients with Crohn’s disease (CD) failing anti- Tumor necrosis factors (TNFs)
however, the effectiveness of VDZ or UST as a third-clas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0e8db9f808dbe7ce7e105fbfbd61d0
https://doi.org/10.3390/jcm10132914